Literature DB >> 9813919

Adherence to management of high blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control.

A Chockalingam1, M Bacher, N Campbell, H Cutler, A Drover, R Feldman, G Fodor, J Irvine, V Ramsden, R Thivierge, G Tremblay.   

Abstract

Adherence or compliance, in the context of medical treatment, refers to how well a patient follows and sticks to the management plan developed with her/his health care provider, which may include pharmacologic agents as well as changes in lifestyle. Adherence is of great concern in asymptomatic conditions such as hypertension, where lack of control may have serious ramifications including end organ damage and premature mortality. To address this issue, the Canadian Coalition for High Blood Pressure Prevention and Control established a national Advisory Committee on Adherence to the Management of High Blood Pressure. The Advisory Committee consisted of 11 members from different disciplines of health care providers. The Committee reviewed all evidences to date and drew up four practical recommendations with respect to patient, provider and environment. Based on Canadian Task Force on Periodic Health Examination's guidelines, all four recommendations can be classified as 'level C' with a quality of evidence of II.

Entities:  

Mesh:

Year:  1998        PMID: 9813919

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  9 in total

1.  Poor compliance: the hidden risk factor.

Authors:  J C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.113

2.  Lifestyle approaches to managing high blood pressure. New Canadian guidelines.

Authors:  R J Petrella
Journal:  Can Fam Physician       Date:  1999-07       Impact factor: 3.275

Review 3.  Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence.

Authors:  Todd M Ruppar; Fabienne Dobbels; Pawel Lewek; Michal Matyjaszczyk; Kaat Siebens; Sabina M De Geest
Journal:  Int J Behav Med       Date:  2015-12

4.  Control of Hypertension among Type II Diabetics.

Authors:  Kawther El-Shafie; Sayed Rizvi
Journal:  Oman Med J       Date:  2010-01

Review 5.  Canadian Hypertension Education Program: the evolution of hypertension management guidelines in Canada.

Authors:  Ross D Feldman; Norman R C Campbell; Katherine Wyard
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

6.  Low-dose combination therapy: why include a diuretic?

Authors:  E D Freis
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Sep-Oct       Impact factor: 3.738

7.  Type 2 diabetes care for patients in a tertiary care setting in UAE: a retrospective cohort study.

Authors:  Layla Alhyas; Yutong Cai; Azeem Majeed
Journal:  JRSM Short Rep       Date:  2012-10-15

8.  Hypertension control and co-morbidities in primary health care centers in Riyadh.

Authors:  Abdulmohsin A Al-Tuwijri; Mohammed Othman Al-Rukban
Journal:  Ann Saudi Med       Date:  2006 Jul-Aug       Impact factor: 1.526

9.  Adherence treatment factors in hypertensive African American women.

Authors:  Marie N Fongwa; Lorraines S Evangelista; Ron D Hays; David S Martins; David Elashoff; Marie J Cowan; Donald E Morisky
Journal:  Vasc Health Risk Manag       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.